Clinical Trial Update: Single Dose Trial of VMX-C001 in Healthy Subjects with and Without FXa Direct Oral Anticoagulant [Phase 1]

View source ↗

Summary

Phase 1 single-dose trial of VMX-C001 in healthy subjects, assessing effects with and without FXa direct oral anticoagulants. The study is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coagulation Disorders

Drugs mentioned

• VMX-C001 (VMX-C001)

Snippet

Sponsor: VarmX B.V. | Conditions: Coagulation Disorder | Phase 1 | Status: ACTIVE_NOT_RECRUITING